Programs, populations, and payments verified via SAMHSA.
- Level of care
- Inpatient · IOP · MAT · Dual Dx · Telehealth
- Service settings
- Outpatient, Residential/24-hour residential, Intensive outpatient treatment, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment, Long-term residential, Short-term residential
- Therapy approaches
- Brief intervention, Cognitive behavioral therapy, Contingency management/motivational incentives, Motivational interviewing, Matrix Model, Relapse prevention, Substance use disorder counseling, Telemedicine/telehealth therapy
- Special populations
- Adolescents, Adult women, Adult men, Criminal justice (other than DUI/DWI)/Forensic clients, Clients with co-occurring mental and substance use disorders, Clients who have experienced trauma
- Medications used
- Acamprosate (Campral®), Buprenorphine with naloxone, Buprenorphine without naloxone, Buprenorphine (extended-release, injectable), Naltrexone (oral), Naltrexone (extended-release, injectable), Medications for HIV treatment, Medications for Hepatitis C treatment, Medication for mental disorders, Medications for pre-exposure to prophylaxis + 2 more
- Recovery supports
- Self-help groups, Housing services, Assistance with obtaining social services, Recovery coach, Mentoring/peer support, Employment counseling or training
- Facility operation
- Private non-profit organization